Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
or

Bausch & Lomb Corp (BLCO)

Bausch & Lomb Corp (BLCO)
15.20 x 1 15.95 x 1
Post-market by (Cboe BZX)
15.56 -0.19 (-1.21%) 03/21/25 [NYSE]
15.20 x 1 15.95 x 1
Post-market 15.66 +0.10 (+0.64%) 16:13 ET
Quote Overview for Fri, Mar 21st, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
15.47
Day High
15.73
Open 15.73
Previous Close 15.75 15.75
Volume 162,500 162,500
Avg Vol 465,290 465,290
Stochastic %K 49.07% 49.07%
Weighted Alpha -13.79 -13.79
5-Day Change +0.21 (+1.37%) +0.21 (+1.37%)
52-Week Range 13.16 - 21.69 13.16 - 21.69
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,484,449
  • Shares Outstanding, K 352,471
  • Annual Sales, $ 4,791 M
  • Annual Income, $ -317,000 K
  • EBIT $ 450 M
  • EBITDA $ 906 M
  • 60-Month Beta 0.49
  • Price/Sales 1.16
  • Price/Cash Flow 8.41
  • Price/Book 0.85

Options Overview Details

View History
  • Implied Volatility 51.61% ( +13.79%)
  • Historical Volatility 18.72%
  • IV Percentile 70%
  • IV Rank 45.78%
  • IV High 96.79% on 02/19/25
  • IV Low 13.47% on 05/14/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 132
  • Volume Avg (30-Day) 123
  • Put/Call OI Ratio 0.48
  • Today's Open Interest 17,720
  • Open Int (30-Day) 17,784

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 0.06
  • Number of Estimates 8
  • High Estimate 0.25
  • Low Estimate -0.02
  • Prior Year 0.07
  • Growth Rate Est. (year over year) -14.29%

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.07 +3.25%
on 03/13/25
Period Open: 15.75
16.15 -3.65%
on 03/07/25
-0.19 (-1.21%)
since 02/21/25
3-Month
15.07 +3.25%
on 03/13/25
Period Open: 18.00
18.55 -16.13%
on 01/02/25
-2.44 (-13.56%)
since 12/20/24
52-Week
13.16 +18.24%
on 05/02/24
Period Open: 16.08
21.69 -28.26%
on 10/14/24
-0.52 (-3.23%)
since 03/21/24

Most Recent Stories

More News
Medical Devices & Supplies - Specialty Stocks Q4 In Review: Globus Medical (NYSE:GMED) Vs Peers

Medical Devices & Supplies - Specialty Stocks Q4 In Review: Globus Medical (NYSE:GMED) Vs Peers

INSP : 164.92 (+1.33%)
ENOV : 39.08 (-0.69%)
GMED : 73.59 (-0.43%)
BLCO : 15.56 (-1.21%)
HAE : 64.00 (-0.37%)
3 Stocks Under $50 Walking a Fine Line

3 Stocks Under $50 Walking a Fine Line

HOG : 24.71 (-2.10%)
BLCO : 15.56 (-1.21%)
KSS : 8.28 (-1.60%)
Bausch Health Stock Pops After-Hours On Q4 Earnings Beat, Bullish Outlook: Retail Confidence Rises

The company’s Solta segment, which includes medical aesthetics, saw Q4 revenue climb 34% to $138 million, fueled by strong demand in South Korea and China.

VSS : 118.59 (-0.29%)
VXUS : 63.46 (-0.78%)
PPH : 92.64 (-0.78%)
BLCO : 15.56 (-1.21%)
BHC : 7.16 (+0.42%)
Globus Medical (GMED) Q4 Earnings: What To Expect

Globus Medical (GMED) Q4 Earnings: What To Expect

INSP : 164.92 (+1.33%)
GMED : 73.59 (-0.43%)
BLCO : 15.56 (-1.21%)
Earnings To Watch: Integer Holdings (ITGR) Reports Q4 Results Tomorrow

Earnings To Watch: Integer Holdings (ITGR) Reports Q4 Results Tomorrow

INSP : 164.92 (+1.33%)
ITGR : 115.16 (-0.97%)
BLCO : 15.56 (-1.21%)
Bausch + Lomb’s (NYSE:BLCO) Q4: Beats On Revenue

Bausch + Lomb’s (NYSE:BLCO) Q4: Beats On Revenue

BLCO : 15.56 (-1.21%)
Bausch + Lomb: Q4 Earnings Snapshot

Bausch + Lomb: Q4 Earnings Snapshot

BLCO : 15.56 (-1.21%)
Bausch + Lomb (BLCO) Reports Earnings Tomorrow: What To Expect

Bausch + Lomb (BLCO) Reports Earnings Tomorrow: What To Expect

INSP : 164.92 (+1.33%)
BLCO : 15.56 (-1.21%)
HAE : 64.00 (-0.37%)
Bausch Health Provides Update on Strategic Alternatives

LAVAL, QC / ACCESS Newswire / February 6, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company" or "Bausch Health"), a global, diversified pharmaceutical company enriching lives through...

BLCO.TO : 22.95 (+1.68%)
BHC.TO : 10.25 (+0.79%)
BLCO : 15.56 (-1.21%)
BHC : 7.16 (+0.42%)
Bausch + Lomb: Q3 Earnings Snapshot

Bausch + Lomb: Q3 Earnings Snapshot

BLCO : 15.56 (-1.21%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Bausch Lomb Corporation is an eye health company. Its product portfolio includes Biotrue(R) and renu(R) multi-purpose solutions, Biotrue(R) ONEday daily disposable contact lenses, LUMIFY(R) redness reliever eye drops, PreserVision(R) AREDS 2 formula eye vitamin and mineral supplements and VYZULTA(R)....

See More

Key Turning Points

3rd Resistance Point 15.96
2nd Resistance Point 15.85
1st Resistance Point 15.70
Last Price 15.56
1st Support Level 15.44
2nd Support Level 15.33
3rd Support Level 15.18

See More

52-Week High 21.69
Fibonacci 61.8% 18.43
Fibonacci 50% 17.42
Fibonacci 38.2% 16.42
Last Price 15.56
52-Week Low 13.16

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Precision Trading with Bollinger Bands: Identifying Breakouts & Reversals